Health Populi November 14, 2024
Jane Sarasohn-Kahn

For health care, there are many uncertainties as we reflect, one week after the 2024 U.S. elections, on probably policy and market impacts that we can expect in 2025 and beyond. In today’s Health Populi post, I’ll reflect on the first of several certainties we-know-we-know about U.S. health citizens and key factors shaping the American health ecosystem.

In this first of several posts on “What Stays True for U.S. Health Care Post #Election2024,” I’ll focus on U.S. consumer dissatisfaction with drug prices — across political party identification.

Let’s set the context with data from a recently-published study from Navitus Health Solutions exploring 2,000 U.S. insured consumers’ perspectives on prescription drug pricing and the role of PBMs (pharmacy benefit managers)....

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Patient / Consumer, Pharma, Pharma / Biotech
Doctors Outraged Republican Congress To Allow Medicare Pay Cut
KFF Health Tracking Poll February 2025: The Public’s Views on Potential Changes to Medicaid
MedPod Today: This Week's Top D.C. Healthcare News
Podcast: The Impact of Trump's Known Health Care Agenda w/ Rebecca Pifer
Will Trump Drug Tariffs Help Or Hurt The U.S.?

Share This Article